Skip to main content
eScholarship
Open Access Publications from the University of California

Improving Treatment Trial Outcomes for Rett Syndrome

  • Author(s): Neul, JL
  • Glaze, DG
  • Percy, AK
  • Feyma, T
  • Beisang, A
  • Dinh, T
  • Suter, B
  • Anagnostou, E
  • Snape, M
  • Horrigan, J
  • Jones, NE
  • et al.

Published Web Location

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610825/
No data is associated with this publication.
Abstract

© The Author(s) 2015. Rett syndrome is a genetically based neurodevelopmental disorder. Although the clinical consequences of Rett syndrome are profound and lifelong, currently no approved drug treatments are available specifically targeted to Rett symptoms. High quality outcome measures, specific to the core symptoms of a disorder are a critical component of well-designed clinical trials for individuals with neurodevelopmental disorders. The Clinical Global Impression Scale is a measure of global clinical change with strong face validity that has been widely used as an outcome measure in clinical trials of central nervous system disorders. Despite its favorable assay sensitivity in clinical trials, as a global measure, the Clinical Global Impression Scale is not specific to the signs and symptoms of the disorder under study. Development of key anchors for the scale, specific to the disorder being assessed, holds promise for enhancing the validity and reliability of the measure for disorders such as Rett syndrome.

Many UC-authored scholarly publications are freely available on this site because of the UC Academic Senate's Open Access Policy. Let us know how this access is important for you.

Item not freely available? Link broken?
Report a problem accessing this item